Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Letue35 

Incyte Corp. diskutieren

Incyte Corp.

WKN: 896133 / Symbol: INCY / Name: Incyte / Aktie / Biotechnologie & medizinische Forschung / Large Cap /

49,50 €
1,15 %

Einschätzung Sell
Rendite (%) -10,48 %
Kursziel 109,14
Veränderung
Endet am 05.05.17

Gewinnmitnahmen

Der Wert hat geflogen und soll in den kommenden Tagen bläst

Einschätzung Sell
Rendite (%) -10,48 %
Kursziel 109,14
Veränderung
Endet am 05.05.17

(Zielkurs erreicht)

Sell Incyte Corp.

Sell Incyte Corp.

Buy Incyte Corp.

Sell Incyte Corp.

Buy Incyte Corp.

Einschätzung Buy
Rendite (%) -23,50 %
Kursziel 106,82
Veränderung
Endet am 07.03.24

Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at JMP Securities. They now have a $113.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for INCY provided by MarketBeat

Einschätzung Sell
Rendite (%) -13,19 %
Kursziel 66,25
Veränderung
Endet am 20.07.24

Incyte Co. (NASDAQ: INCY) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $74.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,72 %
Kursziel 84,09
Veränderung
Endet am 02.08.24

Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $92.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,26 %
Kursziel 85,28
Veränderung
Endet am 21.09.24

Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $91.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,56 %
Kursziel 82,82
Veränderung
Endet am 29.11.24

Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $91.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,64 %
Kursziel 79,21
Veränderung
Endet am 04.12.24

Incyte Co. (NASDAQ: INCY) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $86.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,62 %
Kursziel 72,20
Veränderung
Endet am 13.12.24

Incyte Co. (NASDAQ: INCY) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $78.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,24 %
Kursziel 78,42
Veränderung
Endet am 14.02.25

Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Truist Financial Co. from $91.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,30 %
Kursziel 75,48
Veränderung
Endet am 14.02.25

Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Citigroup Inc. from $82.00 to $81.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,64 %
Kursziel 74,75
Veränderung
Endet am 23.02.25

Incyte Co. (NASDAQ: INCY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $81.00 price target on the stock.
Ratings data for INCY provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,13 %
Kursziel 78,59
Veränderung
Endet am 24.04.25

Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $92.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for INCY provided by MarketBeat